Built to inform

Sign up for the daily newsletters

No, Thank you

Pharma firm opens $136m UAE plant

Julphar's Ras Al Khaimah facility to produce 45m insulin vials a year

Production line at a Julphar plant
Production line at a Julphar plant

Gulf Pharmaceutical Industries, Julphar, has opened its new $136m (AED: 500m) plant in Ras Al Khaimah which will be used for making and distributing insulin.

It will be capablee of producing 1,500kg of insulin a year - or around 45m vials. Capacity will be scaled up based on demand, the company said.

Julphar first began producing insulin eight years ago from crystals imported from Europe, but now produces the crystals in-house.

The company said that the market for insulin is likely to increase over the next few years.

"Some 20 per cent of the Gulf's population now has diabetes with the number likely to double by 2030 if action is not taken to contain the disease," it said.

Most popular


CW Oman Awards 2019: Shortlist and judges to be revealed soon
The eighth edition of the Construction Week Oman Awards will be held on 25 March


Leaders Kuwait 2018: New Kuwait 2035 needs smart city-led contracts
Localisation and contract modernisation are essential for Kuwait's diversification strategy
Construction Week's Leaders Kuwait 2018 summit opens
Speakers from Kuwait's Supreme Council for Planning and Development and CSCEC ME are at today's

Latest Issue

Construction Week - Issue 729
Feb 14, 2019